Antibiotic Action
November 10, 2014
Organizations all over the globe are taking action against drug resistance. Tracey Guise of the British Society for Antimicrobial Chemotherapy (BSAC) is positive about the latest developments.
0 min read
Nov
EMA Pilot Project on Adaptive Licensing
November 10, 2014
Quick fire Q&A with Hans-Georg Eichler, Senior Medical Officer, EMA
0 min read
Game On
November 7, 2014
A business simulation video game called Big Pharma is being made by a UK game studio called Twice Circled. We spoke with game designer and programmer Tim Wicksteed to find out more about the game, and how players will have to tackle the ethical dilemmas of making medicines.
0 min read
Liking Social Pharma
November 7, 2014
Patients and physicians are tweeting, snapchatting, pinning and posting about healthcare, and although many pharma companies still have no idea what any of that means, some are making the leap into the digital world – and seeing results.
0 min read
Global Recall
November 7, 2014
It is the nightmare scenario for any drug firm. And yet, in a world of regulatory rigor and complex supply chains, product recalls are becoming increasingly challenging. Here’s how you can protect your company and customers, should the worst happen.
0 min read
The Long Road to EXCiPACT
November 7, 2014
If I knew six years ago just how much of my time EXCiPACT would take up, would I have even started? A good question! But, actually, I have no regrets; the story of EXCiPACT and its impact, even today, on the pharmaceutical industry makes every second worthwhile.
0 min read
Terminal Inertia
November 7, 2014
It is clear that terminal sterilization is the gold standard for sterile drug manufacture, so why are companies so reluctant to pursue it?
0 min read
Don’t Forget CDx Developers
November 7, 2014
Many drug developers are going ‘full steam ahead’ with personalized medicine strategies. They would be wise to consider a more equitable business model for an essential partner in the process: the developer of the companion diagnostic.
0 min read
Antibiotic Apocalypse: Part II
November 7, 2014
The rise of drug resistance has left us facing a future with few effective antibiotics. Do the next-generation antibiotics in the pipeline offer hope?
0 min read
Adapting to the Future of Licensing
November 7, 2014
With an EMA pilot scheme underway, and ongoing discussion at regulatory agencies worldwide, it looks likely that adaptive licensing will feature in the future drug development landscape. But what will this mean for the development process and the working relationship between regulators, payers, patients and sponsors?
0 min read
Browse by Topics
Interview
Drug Discovery
Development & Clinical
Formulation
Drug Delivery
Bioprocessing
Small Molecules
Cell & Gene
Facilities & Equipment
Outsourcing
Packaging
Supply Chain
Regulation & Standards
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blog